Abstract
Importance Artificial intelligence (AI) foundation models such as Segment Anything Model 2 (SAM 2) offer potential for semi-automated image segmentation with minimal fine-tuning, but their performance in specialized clinical tasks like radiation therapy planning are not well characterized.
Objective To evaluate the performance of SAM 2 in segmenting pre-operative intact prostate and post-operative prostate fossa targets for prostate radiotherapy planning.
Design, Setting, Participants Retrospective cohort study deploying and testing a foundation model for AI segmentation for prostate radiotherapy planning. CT simulation images and radiation plans were obtained from a single academic institution for patients undergoing prostate cancer treatment. Data analysis was performed from September 2024 to February 2025.
Exposures AI segmentation with varying levels of human intervention, ranging from intervals of every 2nd to every 10th ground truth slice provided as input.
Main Outcome and Measures Segmentation accuracy measured by Dice Similarity Coefficient (DSC) and Hausdorff Distance (HD) for intact and post-operative prostate target delineation.
Results While SAM 2 outperformed interpolation in DSC and HD for both intact and post-operative prostate cancer patient cases, the AI segmentation accuracy was significantly better in the intact pre-operative patient cases where anatomic boundaries were better defined than post-operative patient cases. This is especially evident when sparse ground truth was provided simulating lower levels of human intervention.
Conclusions and Relevance AI foundation models show promising application for specialized medical tasks such as prostate cancer radiotherapy segmentation with limited need for fine-tuning or retraining, although their clinical application will require further understanding of task-specific performance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of UT Southwestern Medical Center gave ethical approval for this work (STU 082013-008).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Updated supplemental material section and figure title.
1 Physician-created ground truth mask provided as input every nth slice
2 DSC reported as mean (std)
3 P-value calculated by Mann-Whitney U test comparing SAM 2 and Interpolation performance within corresponding cohort
4 P-value calculated by Mann-Whitney U test comparing SAM 2 performance across cohorts
Data Availability
All data produced in the present study are available upon reasonable request to the authors
